OBiO Tech is committed to becoming a global leader in gene and cell therapy CRO and CDMO to serve our customers worldwide with the best possible. We provide holistic research, development, manufacturing solutions, functional genomics, process and analytical development, IND-enabling CMC, clinical and commercial manufacturing expertise, capabilities, and compliance. Our missing is to "Enable gene therapy for a better life" through quality service to help advance advanced therapeutic products to clinics and manufacturing.
OBiO Tech is built upon ten years of industry experience, focusing only on bringing gene and cell therapies to the next level. Thanks to years of trust and recognition from our customers, by April 2023, as a quality service provider, we have supported over 150 gene and cell therapy programs, of that 25 programs have been approved for clinical trials in the US and China.
OBiO's current services with scale include plasmids, mRNA, AAV vector, oncolytic virus, immuno cell therapy, stem cells, etc. With the newest and largest cGMP facilities in production in the Asian Pacific, we can provide unparalleled skills and capabilities to bring success to more clients worldwide.